🧠 EMP-17 Peptide — Neuroprotective Innovation Without Hematological Risk

Explore the next frontier in peptide research with EMP-17, a synthetic erythropoietin-mimetic peptide designed to deliver the neuroprotective benefits of EPO—without stimulating red blood cell production. Engineered for precision, EMP-17 targets EPO receptors to activate cellular repair and cognitive support pathways in non-human test subjects under controlled laboratory conditions.

🔬 Unlike full-length EPO proteins, EMP-17 offers a smaller, more versatile structure that may cross the blood-brain barrier and support neurological resilience without the risks of thromboembolism or tumor growth.

Key Research Benefits:

• 🧠 Supports Neuroprotection & Synaptic Plasticity

• 🧬 Non-Hematopoietic EPO Receptor Activation

• 🧩 Potential Memory & Cognitive Enhancement

• ⚙️ Investigated for Stroke, Alzheimer’s & Parkinson’s Models

Ideal for advanced research into neurological recovery, cognitive performance, and non-hematopoietic EPO applications.

Building a “NeuroRecovery Stack” with EMP-17, VIP-5, and Epithalon

This product is sold as a research chemical only and not for human use